* Vicarious Surgical Inc RBOT.N reported a quarterly
adjusted
loss of $2.59 per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of $-3.60. The mean expectation of four analysts for the
quarter was for a loss of $2.77 per share. Wall Street expected
results to range from $-3.30 to $-2.40 per share.
* Reported revenue was zero; analysts expected zero.
* Vicarious Surgical Inc's reported EPS for the quarter was
a loss
of $2.59.
* The company reported a quarterly loss of $15.21 million.
* Vicarious Surgical Inc shares had risen by 3.4% this
quarter and
lost 44.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Vicarious
Surgical Inc is $30.00
This summary was machine generated from LSEG data August 13 at
01:32 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -2.77 -2.59 Beat
Mar. 31 2024 -2.85 -3.00 Missed
Dec. 31 2023 -3.75 -1.80 Beat
Sep. 30 2023 -4.27 -3.00 Beat